Abstract : A 31 year old woman was diagnosed with multiple endocrine neoplasia (MEN) 2B at 10 years old. Dark pigmentation gradually developed on her skin and her serum adrenocorticotropic hormone (ACTH) was high, suggesting concurrent ectopic ACTH syndrome (EAS). Corticotropin-releasing hormone (CRH) loading test ruled out Cushing's disease and supported the diagnosis of EAS. Multiple low attenuation mass in the liver was observed in a computed tomography (CT) scan, and was suspected as ectopic ACTH-secreting metastatic tumor from medullary thyroid carcinoma (MTC). ACTH production by MTC is relatively rare, particularly in patients with MEN; patients with ectopic ACTH-secreting liver metastatic tumor from MTC in MEN 2B have never been reported previously.
Introduction
Tumors that arise outside the pituitary gland and secrete adrenocorticotropic hormone (ACTH) are known as ectopic ACTH tumors. Excessive ACTH secretion from such tumors can cause adrenal hyperfunction, which results in the appearance of clinical Cushingʼs features and abnormal laboratory test values; this condition is known as ectopic ACTH syndrome (EAS). In Japan, the etiology of Cushingʼs syndrome includes ectopic ACTH tumors (3.6%) and unknown pathology (5.8%) (i.e., less than 10%), which is similar to that reported in Europe and the United States (9-18%) [1] [2] [3] [4] .
Medullary thyroid carcinoma (MTC) is a rare thyroid malignancy comprising three to five percent of all thyroid cancers in patients with EAS. MTC represents 2.2-7.5% of cases with ectopic ACTH-secreting tumors [5] [6] [7] . In MTC, calcitonin cells (C cells) originating from the neural crest exhibit endocrine functions. Their histopathological features are similar to those of carcinoid and islet cell tumors, and thus produce various hormones and peptides other than calcitonin and carcinoembryonic antigen (CEA). MTC can produce ACTH in up to 40% of cases, as confirmed by immunohistochemistry [8] .
We report here a rare case of ectopic ACTH-secret- (Table 1) , which led to a suspicion of concurrent EAS. Physical examination on admission showed generalized hyperpigmentation of the face as well as on the extensor aspects of the elbows bilaterally and extensor aspect of the interphalangeal joints of both hands. In addition, the characteristics of MEN 2B, such as pachycheilia and multiple lingual tumors, were observed. Cushingʼs features and associated hypercortisolism were not observed after bilateral adrenalectomy, and no complications, such as osteoporosis, hypertension, or hyperglycemia, were identified. However, we suspected ACTH-dependent condition, due to the black pigmentation of the skin. A corticotropin-releasing hormone (CRH) loading test was performed to distinguish EAS from Cushingʼs disease. The basal ACTH values were high and the peak ACTH values were lower than 150% of the basal values;these findings ruled out a diagnosis of Cushingʼs disease and favored a diagnosis of EAS ( Table 1 ). As listed in Table 2 , the levels of various tumor markers, such as neuron-specific enolase (NSE) and pro-gastrin-releasing peptide (pro-GRP), were increased. A CT scan conducted to examine the ACTH secretion site showed no pulmonary nodular shadows, bronchial or pulmonary carcinoid tumors, or mediastinal tumors. A CT of the abdomen identified multiple low-density areas in the right liver lobe, which appeared to have grown in size compared with previous CTs (Fig. 1A ), together with a lead pipelike expansion of the transverse colon, which is characteristic of MEN 2B. A fluorodeoxy-glucose (FDG) positron emission tomography (PET) scan showed no uptake in the chest area, but high uptake in the liver with low attenuation areas in CT (Fig. 1B) . Moreover, the patientʼs CEA and calcitonin levels were markedly elevated, although recurrence of MTC was not observed in neck ultrasonography. Based on the shift in CEA and calcitonin levels ( Fig. 2A) that paralleled the increased tendency of low attenuation hepatic areas in CT (Fig. 2B) , secretion from hepatic metastasis was suspected.
Post contrast magnetic resonance imaging (MRI) of the pituitary gland showed a 4 mm adenoma with slight contrast enhancement of the right sella turcica. The CRH loading test is highly sensitive and specific, with sensitivity of 86% and specificity of 95% [9] , but the patientʼs results were negative for Cushingʼs disease, and thus blood sampling from the pituitary vein was not performed. (Fig.  3A) , occipital bone (Fig. 3B ), cranial base (Fig. 3C) , thoracolumbar vertebrae (Fig. 3D) , and left humeral head (Fig. 3E) . Based on these findings, the final diagnosis was multiple hepatic and bone metastases from MTC, with suspected ACTH-secreting metastatic hepatic foci. 
Discussion
Immunohistochemical analysis has demonstrated that about 40% of cases of MTCs secrete ACTH [8] , with Cushingʼs syndrome diagnosed in only 0.6% of all patients with MTC [6] . Thus, ACTH production by MTC is relatively rare, particularly in patients with MEN. To our knowledge, only five cases have been reported previously [5, [10] [11] [12] . Of the 5 reported cases, 4 were MEN 2A and 1 was MEN 2B [13] . Another reported case had MTC with ectopic ACTH secretion from metastatic hepatic lesions [14] . This case was sporadic and, to date, no similar cases have been reported in patients with MEN. In our case, the EAS was probably caused by the metastatic liver lesions, as it developed after total thyroidectomy. Liver biopsy is required to confirm ACTH/CRH secretion from metastatic liver tumors. However, in this case, since bilateral adrenalectomy had already been performed for pheochromocytoma, it was considered that the secreted ACTH posed no disadvantage on the metabolic phase, apart from the black skin pigmentation. Based on a request by the patient, no further detailed examinations were conducted. SRS is a useful tool for visualization of neuroendocrine tumors (NETs) and thus localization of the primary tumor as well as recurrent and/or metastatic tumors. In Japan, SRS is not yet included in the government-sponsored health insurance program as a diagnostic method for tumor localization, although its usefulness has been reported in Europe and the United States [15] , where it has already been approved. Bronchial carcinoid tumors, which frequently cause EAS, are small with a slow growth rate, and thus are difficult to detect by conventional imaging modalities such as CT and MRI scan [16] . A case of pulmonary carcinoid tumor with high levels of pro-GRP [17] and another case of MEN type 1 with thymus carcinoid tumor [18] have been reported previously. Pulmonary carcinoid tumors might not be detected by SRS because of their small size, so we will monitor the future developments very carefully in this case. This report described a rare case of suspected ectopic ACTH secretion from a liver metastatic lesion by MTC in a patient with MEN. 
